why choose us

First received: January 31, 2024

Clinical Trial: A 16-Week Study to Evaluate the Efficacy, Safety, and Tolerability of GLY-200 in Participants With Obesity

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Obesity

Study Type: INTERVENTIONAL


Official Title: A Phase 2 Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Tolerability of GLY-200 in Participants With Obesity

Brief Summary: This study will evaluate the efficacy, safety, and tolerability of GLY-200 in participants with obesity.

Read more